Regenerative medicine Tempe: what blood-based care involves

Simple care often settles an ordinary flare

Rest the joint briefly from the motion that stirred it. Don't sit all day, though, because long rest can add stiffness. Slow bends or a gentle walk may keep you loose. With heat or cold, you'll know which one feels better.

Notice which motion raises the soreness and when it eases again. Your usual doctor can discuss a brace, cane, medicine, or physical therapy. Some common pain pills aren't safe with every health problem. If home care isn't helping, an exam can sort out what is sore.

Here’s one point that matters. Get prompt medical care if the joint is hot, red, or very swollen. Do the same if it won't hold weight or suddenly won't move. Planned treatment can't come before those problems have been checked.

The exam comes before any blood-based shot

At a visit, say where the joint hurts and which motions are hard. Sleep, stairs, walking, and dressing all count. The provider will check motion, tender areas, strength, and steadiness. If wear or damage seems likely, the provider may order an X-ray.

You'll get different facts from an X-ray and your daily limits. A worn joint may still work fairly well. A mild-looking X-ray can come with real soreness. That's why the hands-on exam matters.

QC Kinetix offers consultations and PRP, or platelet-rich plasma, which starts with a little blood, is spun until the platelets collect in less liquid, and is given through a shot placed in the aching joint. Concentrated PRP is the same kind of blood preparation with more platelets gathered in it. Relief isn't certain, and studies haven't shown that the shot rebuilds worn cartilage. You needn't choose treatment during that first talk.

Sources

1. A meta-analysis of 14 placebo cohorts from 13 Level-1 knee OA injection trials (1,076 patients, KL 1-4) measured what the SALINE arms did. Intra-articular normal saline produced a statistically significant VAS pain improvement at 3 months (MD 12.10) and a larger one at 6 months (MD 16.62), reaching clinically meaningful thresholds. Any uncontrolled report of 'my injection worked' has to clear this bar before it means anything about the injectate.

   Saltzman BM, et al. — The Therapeutic Effect of Intra-articular Normal Saline Injections for Knee Osteoarthritis: A Meta-analysis of Evidence Level 1 Studies.. The American journal of sports medicine, 2017. DOI: 10.1177/0363546516680607.

2. A network meta-analysis in Annals of Internal Medicine showed that placebo treatments in osteoarthritis trials are not equivalent to one another: the delivery route itself changes the response, with intra-articular placebo producing larger effects than oral placebo. This is a structural reason to distrust any comparison of an injected product against a pill, or against no treatment.

   Bannuru RR, et al. — Effectiveness and Implications of Alternative Placebo Treatments: A Systematic Review and Network Meta-analysis of Osteoarthritis Trials.. Annals of internal medicine, 2015. DOI: 10.7326/M15-0623.

3. A Mayo Clinic single-blind placebo-controlled trial used each patient as their own control: 25 patients with BILATERAL knee OA received bone marrow aspirate concentrate in one knee and saline in the other. Pain fell significantly in BOTH knees at 1 week, 3 months and 6 months - and the relief, described by the authors as dramatic, did NOT differ significantly between the BMAC knee and the saline knee. No serious adverse events occurred.

   Shapiro SA, et al. — A Prospective, Single-Blind, Placebo-Controlled Trial of Bone Marrow Aspirate Concentrate for Knee Osteoarthritis.. The American journal of sports medicine, 2017. DOI: 10.1177/0363546516662455.

4. The RESTORE trial - a participant-, injector- and assessor-blinded RCT of 288 adults aged 50+ with symptomatic medial knee OA (Kellgren-Lawrence 2-3) - compared three weekly intra-articular PRP injections against saline placebo, with co-primary endpoints of 12-month knee pain and medial tibial cartilage volume on MRI. PRP did not beat placebo on either. It is the single best-designed test of the specific claim that PRP changes joint structure, and it was negative.

   Bennell KL, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.

5. The AAOS third-edition clinical practice guideline for non-arthroplasty management of knee osteoarthritis is the orthopedic profession's own GRADE-style appraisal of the same options a regenerative clinic sells; it is the benchmark against which any 'regenerative' claim on this topic should be read, and it rates the strongest support for exercise, weight loss and self-management rather than for injectables.

   Brophy RH, et al. — AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition.. The Journal of the American Academy of Orthopaedic Surgeons, 2022. DOI: 10.5435/JAAOS-D-21-01233.

6. FORWARD, the longest disease-modifying osteoarthritis drug trial reported to date, gave intra-articular sprifermin (a recombinant FGF-18) or placebo to knee OA patients and followed 378 of them for 5 years. Sprifermin produced a significant, sustained dose-response INCREASE in total femorotibial cartilage thickness versus placebo - and WOMAC pain improved about 50% from baseline in ALL groups, including placebo. It is the cleanest demonstration in the literature that adding measurable cartilage and relieving pain are two different results, and that one does not deliver the other.

   Eckstein F, et al. — Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study.. Annals of the rheumatic diseases, 2021. DOI: 10.1136/annrheumdis-2020-219181.